The U.S. Senate Committee on Health, Education, Labor and Pensions unanimously recommended a measure designed to improve health care information technology.The purpose of the “Improving Health Information Techonology Act” (S. 2511) is to simplify information sharing among doctors and allow patients easier access to their own medical records. The bill focuses on the use of the electronic health record — a real-time digital version of a patient’s medical chart — to allow for central record keeping of a patient’s entire medical history, including medications prescribed, treatment plans, immunization records, allergies, radiology imaging and lab results. The goal is to allow immediate and secure access to all authorized users, including patients and providers.
Glaukos Corporation to Release Fourth Quarter & Full Year 2015 Financial Results after Market Close on March 1
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, plans to release fourth quarter and full year 2015 financial results after the market close on Tuesday, March 1, 2016. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m.
PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment 2015-2024 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/hc7wft/pharmapoint_dry) has announced the addition of the “PharmaPoint: Dry Eye Syndrome – Global Drug Forecast and Market Assessment to 2024” report to their off…
Minimally invasive glaucoma surgery increasingly performed by anterior segment surgeons
Anterior segment surgeons are increasingly performing minimally invasive glaucoma surgery in their patients with mild to moderate disease, especially in conjunction with cataract surgery.“What these procedures have done is brought effective glaucoma surgery into the hands of mainstream cataract surgeons who prior to these procedures did not routinely perform glaucoma surgical procedures,” OSN Technology Board Member Jodi I. Luchs, MD, FACS, said. Moreover, minimally invasive glaucoma surgery (MIGS) “can produce a significant difference in clinical outcomes, reducing intraocular pressure and relieving the need to use topical medications in many cases,” he said.
Letter to the Editor
To the Editor:I am submitting a counterpoint to the apologetics provided by Drs. Gustafson and Lindstrom regarding the pricing of Omidria in the Nov. 10, 2015, issue of Ocular Surgery News. I offer some “outside of the beltway” perspective, characterized by Allison Weber Shuren, MSN, JD, as “misguided” at the 2015 ACES/SEE meeting. Please note that all three are paid consultants to Omeros.
Working with industry as a speaker, investigator and consultant
Over the past dozen years, I have enjoyed working with many ophthalmic companies to design new devices, evaluate and improve current products, and educate fellow physicians about their use. This has given me the opportunity to work with the brightest m…